Life Sciences & The Law

Series Overview:

“We Bring Good Things to Life” was an advertising slogan used by General Electric between 1979 and 2003, focused mainly on General Electric’s appliances and lighting fixtures. We’d argue that it would be an even better slogan for the Life Sciences industry.

The Life Sciences Industry encompasses companies and organizations that are dedicated to researching, developing, manufacturing, and distributing products and technologies to improve human and animal health. Key sectors within life sciences include biotechnology, pharmaceuticals, medical devices, and diagnostics. The industry’s work ranges from bench research and small-scale manufacturing to performing small and large-scale clinical trials, developing manufacturing processes on a commercial scale, working closely with regulatory agencies, to developing pricing, marketing, and distribution strategies. The life cycle of a drug or medical device often involves many parties controlling the product at various times, involving the bench of university researchers, development by small startup companies, commercialization by larger industry players, diversification by sublicensees, and distribution by resellers.

Life sciences is a highly regulated field due to its direct impact on health and safety, with strict compliance standards overseen by regulatory bodies like the FDA in the United States and EMA in Europe. The industry is characterized by high research and development (R&D) costs, long development timelines, and significant investment in innovation and technology. The life sciences industry is also increasingly interdisciplinary, intersecting with data science, artificial intelligence, and bioinformatics to drive advancements in personalized medicine, gene therapy, and diagnostics.

Webinars in this Series:

---

---

Share this Webinar Series: